Predicta Biosciences

BiotechnologySeries ACambridge, USpredictabiosciences.com

Latest round

Series A

Last raised

Oct 2025

Total raised

$29M

Investors

8

About Predicta Biosciences

, operates as a healthtech company providing precision oncology for businesses that uses multiomics to create cutting-edge medical and diagnostic tools. In October 2025, Predicta Biosciences, Inc. Predicta Biosciences, Inc. developed precision oncology for transforming diagnostic and therapeutic tools for the patients. The company offers diagnostic products that eliminates invasive bone-marrow biopsies, instead utilizing small blood-based samples. The Predicta platform captures multi-omics and immune system data to build a clinical database. In addition, the firm provides artificial intelligence-based tools that mines the data to discover novel therapeutic targets and immune signatures.

Who invested in Predicta Biosciences

8 investors across 2 rounds

See all investors in Predicta Biosciences

Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.

Funding rounds

  1. Series A

    Oct 1, 2025

    Amount

    $23M

    Investors

    Locked

  2. Seed

    Jul 16, 2024

    Amount

    $5.2M

    Investors

    Locked

Questions about Predicta Biosciences

Who invested in Predicta Biosciences?

Predicta Biosciences has 8 investors on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.

How much funding has Predicta Biosciences raised?

Predicta Biosciences has raised 2 venture rounds. Sign up free to see how much each round raised and the total.

When did Predicta Biosciences last raise money?

Predicta Biosciences's most recent round on record is a Series A, in Oct 2025.

What does Predicta Biosciences do?

, operates as a healthtech company providing precision oncology for businesses that uses multiomics to create cutting-edge medical and diagnostic tools.

Where is Predicta Biosciences headquartered?

Predicta Biosciences is headquartered in Cambridge, US.

Which VCs invest in companies like Predicta Biosciences?

Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at Predicta Biosciences's stage. Their profiles are linked below.

Raising like Predicta Biosciences? Find the right VCs.

Capital Atlas matches your startup to active investors by stage, sector and region.

Free to start. Upgrade when you're ready to reach out.